Skip navigation
Speakers

Evaluation Methods & Risk Mitigation Strategies to Drive an Effective Diligence Process

November 30-December 1, 2017
  • Philadelphia, PA

ROBERT ABOUD
Principal
Faber Daeufer & Itrato PC

CATHERINE BAILLIS
Vice President, Head of Business Development Operations,
Business Development and Licensing
Sanofi

Subin Baral
Partner/Principal, Transaction Advisory Services – Life Sciences
Ernst & Young LLP

DAVID R. BAUER
Counsel
Davis Polk & Wardwell LLP

BONNIE CHEN
Associate
Davis Polk & Wardwell LLP

LAWRENCE COGSWELL, PhD
Principal
Hamilton Brook Smith Reynolds

PHILIP DATLOW
Senior Counsel II, Intellectual Property
Boehringer Ingelheim

Shivang Dave, PhD
Chief Executive Officer
PlenOptika

DEREK DEVGUN
Senior Legal Specialist – M&A
Medtronic

Adam H. Golden
Partner
Hogan Lovells US LLP

Sal Mannarino
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

MARTIN LEHR,
Co-Founder and CEO
Context Therapeutics

CARYN NUTT
Corporate Counsel
Gilead Sciences

BRUCE POKRAS
Senior Corporate Counsel
Pfizer Inc

MARC SCHWABISH, PhD
US Head, Pharma Business Development & Licensing
Bayer

CHRIS SLAVINSKY
Assistant General Counsel
Pfizer Inc

Jeff Stoll
Managing Director, Parthenon-EY
Ernst & Young LLP

DR. SETH B. WHITELAW
President and CEO, Whitelaw Compliance Group, LLC;
Former Compliance Officer, R&D, GlaxoSmithKline

DAN WOLF
Senior Director, Corporate Development
Medtronic

DONNA J. WREN
Senior Counsel
Faber Daeufer & Itrato PC

D. HAMISH WRIGHT, PhD
Director, Business Developing & Licensing
Merck Research Laboratories

ROBERT ABOUD
Principal
Faber Daeufer & Itrato PC

CATHERINE BAILLIS
Vice President, Head of Business Development Operations,
Business Development and Licensing
Sanofi

Subin Baral
Partner/Principal, Transaction Advisory Services – Life Sciences
Ernst & Young LLP

DAVID R. BAUER
Counsel
Davis Polk & Wardwell LLP

BONNIE CHEN
Associate
Davis Polk & Wardwell LLP

LAWRENCE COGSWELL, PhD
Principal
Hamilton Brook Smith Reynolds

PHILIP DATLOW
Senior Counsel II, Intellectual Property
Boehringer Ingelheim

Shivang Dave, PhD
Chief Executive Officer
PlenOptika

DEREK DEVGUN
Senior Legal Specialist – M&A
Medtronic

Adam H. Golden
Partner
Hogan Lovells US LLP

Sal Mannarino
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

MARTIN LEHR,
Co-Founder and CEO
Context Therapeutics

CARYN NUTT
Corporate Counsel
Gilead Sciences

BRUCE POKRAS
Senior Corporate Counsel
Pfizer Inc

MARC SCHWABISH, PhD
US Head, Pharma Business Development & Licensing
Bayer

CHRIS SLAVINSKY
Assistant General Counsel
Pfizer Inc

Jeff Stoll
Managing Director, Parthenon-EY
Ernst & Young LLP

DR. SETH B. WHITELAW
President and CEO, Whitelaw Compliance Group, LLC;
Former Compliance Officer, R&D, GlaxoSmithKline

DAN WOLF
Senior Director, Corporate Development
Medtronic

DONNA J. WREN
Senior Counsel
Faber Daeufer & Itrato PC

D. HAMISH WRIGHT, PhD
Director, Business Developing & Licensing
Merck Research Laboratories